1-4 of 4
Brian J. Crowley
Close
Sort by
Journal Articles

The Jak2 V617F oncogene associated with myeloproliferative diseases requires a functional FERM domain for transformation and for expression of the Myc and Pim proto-oncogenes

Gerlinde Wernig, Jeffrey R. Gonneville, Brian J. Crowley, Margret S. Rodrigues, Mamatha M. Reddy, Heidi E. Hudon, Christoph Walz, Andreas Reiter, Klaus Podar, Yohan Royer, Stefan N. Constantinescu, Michael H. Tomasson, James D. Griffin, D. Gary Gilliland, Martin Sattler
Journal: Blood
Blood (2008) 111 (7): 3751–3759.
https://doi.org/10.1182/blood-2007-07-102186
Published: 2008
Journal Articles

The Jak2 V617F Oncogene Associated with Polycythemia Vera Requires a Functional FERM Domain for Transformation and for Expression of the Myc and Pim Proto-Oncogenes.

Martin Sattler, PhD, Brian J. Crowley, Jeffrey R. Gonneville, Jeremy Ho, Heidi H. Hudon, Klaus Podar, M.D., Ph.D., Yohan Royer, Stefan N. Constantinescu, M.D., Ph.D., James D. Griffin, M.D.
Journal: Blood
Blood (2006) 108 (11): 3611.
https://doi.org/10.1182/blood.V108.11.3611.3611
Published: 2006
Journal Articles

A sensitive high-throughput method to detect activating mutations of Jak2 in peripheral-blood samples

Martin Sattler, Christoph Walz, Brian J. Crowley, Eva Lengfelder, Pasi A. Jänne, Andrew M. Rogers, Yanan Kuang, Robert J. Distel, Andreas Reiter, James D. Griffin
Journal: Blood
Blood (2006) 107 (3): 1237–1238.
https://doi.org/10.1182/blood-2005-07-2899
Published: 2006
Journal Articles

The Jak2V617F Oncogene Associated with Polycythemia Vera Regulates G1/S-Phase Transition.

Martin Sattler, PhD, Christoph Walz, Brian J. Crowley, BS, Jessica L. Gramlich, BS, Kendra L. King, Klaus Podar, MD, James D. Griffin, MD
Journal: Blood
Blood (2005) 106 (11): 3510.
https://doi.org/10.1182/blood.V106.11.3510.3510
Published: 2005